fbpx

Latest News


Diagnostic labelling versus the treatable trait approah: diagram from our latest ERJ publication - Letting the right one in: evaluating the generalisability of clinical trials

Letting the right one in: evaluating the generalisability of clinical trials

December 16, 2018

"Diagnostic labelling" harms targeted therapy research in airways disease. We make a call to adopt the "treatable trait" approach with our latest publication in the European Respiratory Journal: http://erj.ersjournals.com/content/52/6/1802218 Shrimanker R, Beasley R, Kearns C. Letting the right one in: evaluating the generalisability of clinical trials. Eur Respir J 2018; 52: 1802218 [https://doi.org/10.1183/13993003.02218- 2018].

Read more about this

Video podcast: NZ Adult Asthma Guidelines: A Quick Reference Guide.

November 21, 2018

Research Review has published a new video podcast providing an outline of the NZ Adult Asthma Guidelines published in November 2016. The presentation is by Professor Richard Beasley, Physician at Wellington Regional Hospital, and Director of the Medical Research Institute of New Zealand. The purpose of the Asthma Foundation of New Zealand Quick Reference Guide is to provide simple, practical, evidence-based recommendations for the diagnosis, assessment and management of asthma in adults in a quick reference format. Professor Beasley also focuses on the changes to the guidelines since they were last updated in 2002. You can watch the video podcast here: https://www.researchreview.co.nz/nz/Pages/podcasts-details-public.aspx?site=nz&pid=76  

Watch the video here

Healthy vs COPD lungs.

Our latest COPD publication featured on national News

October 17, 2018

Our latest publication on COPD treatment was discussed on Newshub's 6pm national news. You can watch the segment here (skip to 20:36): https://www.threenow.co.nz/shows/newshub-6pm/tuesday-16-october-2018/122217/M25466-114 and read the open-access publication here: https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-018-0720-7

Read more about this

repeated oxygen-driven nebulisation leads to a clinically relevant increase in blood carbon dioxide levels in acute exacerbations of COPD, a new study from MRINZ finds

Oxygen-driven nebulisation leads to clinically relevant rise in blood carbon dioxide in acute exacerbation of COPD

October 15, 2018

A new study from MRINZ has demonstrated that repeated oxygen-driven nebulisation leads to a clinically relevant increase in blood carbon dioxide levels in acute exacerbations of COPD, compared to air-driven nebulisation. You can read the full open-access paper here: https://bmcpulmmed.biomedcentral.com/articles/10.1186/s12890-018-0720-7

Read more about this

PIPPA Tamariki milestone: 250 recruited

PIPPA Tamariki milestone: 250 recruited!

October 14, 2018

PIPPA bear is delighted to announce that the PIPPA Tamariki team has reached a new recruitment milestone of 250 Tamariki! Thank you to all the PIPPA Tamariki whānau taking part in this important study on childhood asthma. Well done also to our teams at Wellington, Auckland, and Middlemore hospitals for helping reach this milestone. Click here to find out more about the study. Onwards!

Read more about this

PIPPA bear teams up with kiwi mums to crack the case on asthma

PIPPA bear teams up with kiwi kids to crack the case on asthma…

September 9, 2018

Introducing PIPPA bear, our new mascot for the PIPPA Tamariki study, which is investigating the potential role of fever medicines in the development of childhood asthma. Read more about the study here: https://pippatamariki.ac.nz/2018/09/05/pippa-bear-teams-up-with-kiwi-kids-to-crack-the-case-on-asthma/

Read more about this

Intensive care study informs best practice for transfusion in open heart surgery

Elderly patients may benefit from less blood in open heart surgery

September 6, 2018

An interesting study from the anaesthetic team at MRINZ has recently concluded, showing that patients over 75 years old appear to benefit from less transfusion following open heart surgery.  It also appears that all patients do just as well transfusing to less aggressive haemoglobin targets than is standard practice. This work could lead to better use of blood stocks, reduce pressure on donors, and improve outcomes for older patients. Listen to Dr Shay McGuinness, an intensive care doctor, is one of the lead investigators of the study speaking on Radio New Zealand here, or read the press article in the New...

Read more about this

Sing your lungs out!

May 3, 2018

Great video about the SYLO programme which uses singing to help manage the symptoms of chronic lung disease. The project started in Wellington in 2014 and is still going strong!

Watch the video here

First Pharmacy Research Network Study finishes recruitment!

January 30, 2018

Over the past three years MRINZ has been developing a unique capability in conducting randomised controlled trials across over 70 pharmacies in New Zealand. The cold sores study looked at a new honey based treatment for this common and painful condition, completing recruitment of 950 participants just before Christmas 2017. The project has been highly successful with a number of subsequent studies in development for this year with our pharmacy investigators and a new, accessible trials network allowing smaller NZ biotech companies to gain clinical evidence or their products. Results and more news soon!

Read more about this

MRINZ influenza study wins the Fukuchi Respirology award

December 13, 2017

The Fukuchi award is for the best original research paper published in Respirology journal. Here Dr Sarah Jefferies reports the findings of our award winning study looking at paracetamol use in influenza.

Watch the video here

Older posts